The Effect of Combined Angiotensin-Converting Enzyme Inhibition and Calcium Antagonism on Allograft Coronary Vasculopathy Validated by Intravascular Ultrasound

Hypertension is a potential risk factor for allograft coronary vasculopathy. We evaluated the efficacy of angiotensin-converting enzyme (ACE) inhibitors and calcium antagonists, and their combined use, on the development of coronary vasculopathy in hypertensive heart transplant recipients. Eighty-tw...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of heart and lung transplantation 2005-08, Vol.24 (8), p.1033-1038
Hauptverfasser:	Erinc, Kursad, Yamani, Mohamad H., Starling, Randall C., Crowe, Tim, Hobbs, Robert, Bott-Silverman, Corinne, Rincon, Gustavo, Young, James B., Feng, Jingyuan, Cook, Daniel J., Smedira, Nicholas, Tuzcu, E. Murat
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angiotensin-Converting Enzyme Inhibitors - administration & dosage Biological and medical sciences Calcium Channel Blockers - administration & dosage Cardiology. Vascular system Case-Control Studies Coronary Disease - diagnostic imaging Coronary Disease - drug therapy Coronary Disease - physiopathology Coronary heart disease Dose-Response Relationship, Drug Drug Administration Schedule Drug Therapy, Combination Female Follow-Up Studies Graft Rejection Graft Survival Heart Heart Transplantation - adverse effects Heart Transplantation - methods Humans Hypertension - complications Male Medical sciences Middle Aged Multivariate Analysis Postoperative Complications - diagnosis Postoperative Complications - drug therapy Probability Reference Values Severity of Illness Index Statistics, Nonparametric Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the heart Survival Rate Treatment Outcome Ultrasonography, Interventional
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!